QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.
HILDEN, Germany & GERMANTOWN, Md.–(BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has signed agreements to acquire a 96% majority ownership stake in BLIRT SA (Polish Stock Exchange: BLR), a manufacturer of recombinant enzymes for the life science industry based in Gdansk, Poland. ...